Mannose inhibits NSCLC growth via the OGT/hnRNP R/JUN/IL-8 axis and synergistically enhances the antitumor efficacy of immune checkpoint inhibitors. The gene discussed is CXCL8; the disease is non-small cell lung carcinoma.